Patients with an eosinophilic COPD phenotype exhibit a T2-high inflammation driven by cytokines like IL-5, IL-4, and IL-13, which promotes eosinophil recruitment and activation in both the bronchial and sinus mucosa. The gene discussed is IL5; the disease is chronic obstructive pulmonary disease.